REVELATION BIOSCIENCES INC REVBW
*W EXP 01/10/202 · Equity WRT · CUSIP 76135L119
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersSan Diego, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.02.
Trends to Q3 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 13 |
| Q4 2022 | 12 |
| Q1 2023 | 18 |
| Q2 2023 | 13 |
| Q3 2023 | 15 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 2 | 3 |
| Q1 2023 | 9 | 3 |
| Q2 2023 | 0 | 7 |
| Q3 2023 | 5 | 1 |
Biggest buyers
| Pine Valley Investments Ltd Liability Co | Added | +205.8k |
| UBS Group AG | New | +78.0k |
| COWEN AND COMPANY, LLC | Added | +1.8k |
| CITADEL ADVISORS LLC | Added | +1.8k |
| CLEAR STREET LLC | New | +100 |
Biggest sellers
| WOLVERINE ASSET MANAGEMENT LLC | Reduced | -1.8k |
Insider purchases and sales in Q3 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 1 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 1 | — | 0 | — | — |
| Q3 2023 | 0 | — | 1 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2023-09-28 | TIDMARSH GEORGE F Director · By Trust | Sold | —1.4k shares |
| 2023-09-18 | TIDMARSH GEORGE F Director | Sold | —4.0k shares |
| 2023-09-15 | TIDMARSH GEORGE F Director | Sold | —9.5k shares |
| 2023-09-14 | TIDMARSH GEORGE F Director | Sold | —12.0k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2023
| Manager | Shares | Change |
|---|---|---|
| Linden Advisors LP 0.00% of their portfolio | 715.8k $10.6k | Unchanged |
| Pine Valley Investments Ltd Liability Co 0.00% of their portfolio | 249.7k $4.2k | Added +205.8k |
| Yakira Capital Management, Inc. 0.00% of their portfolio | 246.9k $4.2k | Unchanged |
| Walleye Capital LLC 0.00% of their portfolio | 187.0k $3.2k | Unchanged |
| Walleye Trading LLC 0.00% of their portfolio | 105.0k $1.8k | Unchanged |
| COWEN AND COMPANY, LLC 0.00% of their portfolio | 100.1k $1.7k | Added +1.8k |
| UBS Group AG 0.00% of their portfolio | 78.0k $1.3k | New |
| Ayrton Capital LLC 0.01% of their portfolio | 75.0k $1.3k | Unchanged |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 72.2k $1.2k | Reduced -1.8k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 50.0k $845 | Unchanged |
| Privium Fund Management B.V. 0.00% of their portfolio | 44.0k $744 | Unchanged |
| EQUITEC PROPRIETARY MARKETS, LLC 0.00% of their portfolio | 20.0k $338 | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 16.5k $279 | Added +1.8k |
| CLEAR STREET LLC 0.00% of their portfolio | 100 $2 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |